4
Changes in Ownership
Mirum Pharmaceuticals, Inc. Filed Acc 0001415889-25-015570
Director sold 8,203 shares at an average $46.06 ($377,843)
- Director acquired 2,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ramasastry Saira Director | 2025-06-02 | Sale | −5,703 | $46.20 | $263,492 | 0 | D |
| Ramasastry Saira Director | 2025-06-03 | Option exercise | +2,500 | $14.12 | $35,300 | 2,500 | D |
| Ramasastry Saira Director | 2025-06-03 | Sale | −2,500 | $45.74 | $114,352 | 0 | D |
| Derivatives | |||||||
| Ramasastry Saira Director | 2025-06-03 | Option exercise · Stock Option (right to buy) | −2,500 | 0 | D | ||
| Open-market sales · 8,203 sh · avg $46.06 · $377,843 | |||||||
Loading xslF345X05/form4-06042025_080640.xml…